206 related articles for article (PubMed ID: 27217478)
1. Neonatal Phototherapy and Infantile Cancer.
Wickremasinghe AC; Kuzniewicz MW; Grimes BA; McCulloch CE; Newman TB
Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27217478
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Cohort Study of Phototherapy and Childhood Cancer in Northern California.
Newman TB; Wickremasinghe AC; Walsh EM; Grimes BA; McCulloch CE; Kuzniewicz MW
Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27217477
[TBL] [Abstract][Full Text] [Related]
3. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy.
Chang PW; Kuzniewicz MW; McCulloch CE; Newman TB
Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28196932
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: a nested case-control study.
Kuzniewicz MW; Escobar GJ; Wi S; Liljestrand P; McCulloch C; Newman TB
J Pediatr; 2008 Aug; 153(2):234-40. PubMed ID: 18534217
[TBL] [Abstract][Full Text] [Related]
5. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use.
Kuzniewicz MW; Escobar GJ; Newman TB
Pediatrics; 2009 Oct; 124(4):1031-9. PubMed ID: 19786442
[TBL] [Abstract][Full Text] [Related]
6. Association Between Neonatal Phototherapy Exposure and Childhood Neoplasm.
Bugaiski-Shaked A; Shany E; Mesner O; Sergienko R; Wainstock T
J Pediatr; 2022 Jun; 245():111-116. PubMed ID: 35120988
[TBL] [Abstract][Full Text] [Related]
7. Risk of Autism Associated With Hyperbilirubinemia and Phototherapy.
Wu YW; Kuzniewicz MW; Croen L; Walsh EM; McCulloch CE; Newman TB
Pediatrics; 2016 Oct; 138(4):. PubMed ID: 27669736
[TBL] [Abstract][Full Text] [Related]
8. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.
Newman TB; Liljestrand P; Jeremy RJ; Ferriero DM; Wu YW; Hudes ES; Escobar GJ;
N Engl J Med; 2006 May; 354(18):1889-900. PubMed ID: 16672700
[TBL] [Abstract][Full Text] [Related]
9. Aggressive vs. conservative phototherapy for infants with extremely low birth weight.
Morris BH; Oh W; Tyson JE; Stevenson DK; Phelps DL; O'Shea TM; McDavid GE; Perritt RL; Van Meurs KP; Vohr BR; Grisby C; Yao Q; Pedroza C; Das A; Poole WK; Carlo WA; Duara S; Laptook AR; Salhab WA; Shankaran S; Poindexter BB; Fanaroff AA; Walsh MC; Rasmussen MR; Stoll BJ; Cotten CM; Donovan EF; Ehrenkranz RA; Guillet R; Higgins RD;
N Engl J Med; 2008 Oct; 359(18):1885-96. PubMed ID: 18971491
[TBL] [Abstract][Full Text] [Related]
10. Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates.
Horn D; Ehret D; Gautham KS; Soll R
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013277. PubMed ID: 34228352
[TBL] [Abstract][Full Text] [Related]
11. A Simpler Prediction Rule for Rebound Hyperbilirubinemia.
Chang PW; Newman TB
Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31196939
[TBL] [Abstract][Full Text] [Related]
12. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.
Bhutani VK; Stark AR; Lazzeroni LC; Poland R; Gourley GR; Kazmierczak S; Meloy L; Burgos AE; Hall JY; Stevenson DK;
J Pediatr; 2013 Mar; 162(3):477-482.e1. PubMed ID: 23043681
[TBL] [Abstract][Full Text] [Related]
13. Update on Phototherapy and Childhood Cancer in a Northern California Cohort.
Digitale JC; Kim MO; Kuzniewicz MW; Newman TB
Pediatrics; 2021 Nov; 148(5):. PubMed ID: 34716218
[TBL] [Abstract][Full Text] [Related]
14. Genetic Factors and Delayed TSB Monitoring and Treatment as Risk Factors Associated with Severe Hyperbilirubinemia in Term Neonates Admitted for Phototherapy.
Boo NY; Sin S; Chee SC; Mohamed M; Ahluwalia AK; Ling MM; Ong HK
J Trop Pediatr; 2020 Dec; 66(6):569-582. PubMed ID: 32577754
[TBL] [Abstract][Full Text] [Related]
15. Phototherapy use in jaundiced newborns in a large managed care organization: do clinicians adhere to the guideline?
Atkinson LR; Escobar GJ; Takayama JI; Newman TB
Pediatrics; 2003 May; 111(5 Pt 1):e555-61. PubMed ID: 12728109
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Home Phototherapy for Neonatal Hyperbilirubinemia.
Chang PW; Waite WM
J Pediatr; 2020 May; 220():80-85. PubMed ID: 32067781
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia.
Elhawary IM; Abdel Ghany EAG; Aboelhamed WA; Ibrahim SGE
World J Pediatr; 2018 Aug; 14(4):350-356. PubMed ID: 29464578
[TBL] [Abstract][Full Text] [Related]
18. Hour-Specific Total Serum Bilirubin Percentiles for Infants Born at 29-35 Weeks' Gestation.
Jegathesan T; Ray JG; Bhutani VK; Keown-Stoneman CDG; Campbell DM; Shah V; Berger H; Hayeems RZ; Sgro M;
Neonatology; 2021; 118(6):710-719. PubMed ID: 34710869
[TBL] [Abstract][Full Text] [Related]
19. Cochrane Review: Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.
Okwundu CI; Okoromah CA; Shah PS
Evid Based Child Health; 2013 Jan; 8(1):204-49. PubMed ID: 23878128
[TBL] [Abstract][Full Text] [Related]
20. Discharge of newborns with risk factors of severe hyperbilirubinemia: description of a hospital at home-based care monitoring and phototherapy.
Coquery SS; Georges A; Cortey A; Floch C; Avran D; Gatbois E; Mehler-Jacob C; de Stampa M
Eur J Pediatr; 2022 Aug; 181(8):3075-3084. PubMed ID: 35695955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
